Fevipiprant is a potent, selective antagonist of the CRTH2 receptor, investigated in clinical development for the treatment of inflammatory conditions such as asthma and inflammatory bowel disease. By… Read more




![Chemical structure of 2,6-Dimethyl-1H-pyrrolo[2,3-b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1255099-47-8-26-Dimethyl-1H-pyrrolo23-bpyridine.png&w=3840&q=75)




Fevipiprant is a potent, selective antagonist of the CRTH2 receptor, investigated in clinical development for the treatment of inflammatory conditions such as asthma and inflammatory bowel disease. By modulating this receptor, the compound aims to inhibit the activation and migration of eosinophils and other inflammatory cells. This category provides essential analytical tools for pharmaceutical research, including Fevipiprant reference standards and characterized metabolites like Fevipiprant acyl glucuronide. Laboratories utilize these high-quality compounds, alongside stable isotope labelled versions such as Fevipiprant-d5 and Fevipiprant acyl glucuronide-d5, to perform rigorous impurity profiling, method validation, and precise quantitative analysis in pharmacokinetic studies. The collection also includes critical synthetic intermediates, such as various substituted pyridinemethanesulfonyl chlorides, which support the synthesis and development processes required for maintaining strict quality control standards throughout drug manufacturing and regulatory evaluation.